Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapyKuei C Lee, Bradford A Moffat, Anne F Schott, et al.
Breast Cancer Research and Treatment|August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.
Pharmacogenomics|December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposureLauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Breast Cancer Research and Treatment|July 8, 2021
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trialLauren P Wallner, Paul Abrahamse, Joan G Gargaro, et al.
Annals of Surgical Oncology|September 12, 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrenceKandice E Kilbride, M Catherine Lee, Alexis V Nees, et al.
The Oncologist|January 24, 2012
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430Anne F Schott, William E Barlow, Kathy S Albain, et al.
Pageof 6